中国中医药信息杂志
中國中醫藥信息雜誌
중국중의약신식잡지
CHINESE JOURNAL OF INFORMATION ON TRADITIONAL CHINESE MEDICINE
2014年
5期
37-39
,共3页
叶志光%李惠%苏雪媚%曾庆祥%丘文静%舒小妹%曾振强%黄伟强%王静波
葉誌光%李惠%囌雪媚%曾慶祥%丘文靜%舒小妹%曾振彊%黃偉彊%王靜波
협지광%리혜%소설미%증경상%구문정%서소매%증진강%황위강%왕정파
支气管哮喘%参蛤散%临床疗效%肺功能%嗜酸细胞计数%嗜酸性粒细胞阳离子蛋白
支氣管哮喘%參蛤散%臨床療效%肺功能%嗜痠細胞計數%嗜痠性粒細胞暘離子蛋白
지기관효천%삼합산%림상료효%폐공능%기산세포계수%기산성립세포양리자단백
bronchial asthma%Shenge powder%clinical efficacy%lung function%eosinophil count%eosinophil cationic protein
目的:观察加味参蛤散治疗缓解期支气管哮喘的临床疗效及对肺功能和血液学指标的影响。方法采用随机数字表法,将80例缓解期支气管哮喘患者随机分为治疗组和对照组,每组40例。治疗组予加味参蛤散,对照组予沙美特罗替卡松粉吸入剂。4周为1个疗程,连服3个疗程。观察临床疗效、肺功能改善情况及不良反应,检测治疗前后血嗜酸细胞计数(EOC)、血嗜酸性粒细胞阳离子蛋白(ECP)。结果治疗组总有效率为95.00%(38/40),对照组为80.00%(32/40),治疗组优于对照组(P<0.05);治疗组1秒用力呼气容积(FEV1)占预计值百分比及FEV1/用力肺活量值均较治疗前显著升高,且优于对照组(P<O.05);2组患者EOC、ECP均降低(P<0.05)。结论加味参蛤散治疗缓解期支气管哮喘疗效显著,可明显改善患者的肺功能,抑制嗜酸性细胞聚集。
目的:觀察加味參蛤散治療緩解期支氣管哮喘的臨床療效及對肺功能和血液學指標的影響。方法採用隨機數字錶法,將80例緩解期支氣管哮喘患者隨機分為治療組和對照組,每組40例。治療組予加味參蛤散,對照組予沙美特囉替卡鬆粉吸入劑。4週為1箇療程,連服3箇療程。觀察臨床療效、肺功能改善情況及不良反應,檢測治療前後血嗜痠細胞計數(EOC)、血嗜痠性粒細胞暘離子蛋白(ECP)。結果治療組總有效率為95.00%(38/40),對照組為80.00%(32/40),治療組優于對照組(P<0.05);治療組1秒用力呼氣容積(FEV1)佔預計值百分比及FEV1/用力肺活量值均較治療前顯著升高,且優于對照組(P<O.05);2組患者EOC、ECP均降低(P<0.05)。結論加味參蛤散治療緩解期支氣管哮喘療效顯著,可明顯改善患者的肺功能,抑製嗜痠性細胞聚集。
목적:관찰가미삼합산치료완해기지기관효천적림상료효급대폐공능화혈액학지표적영향。방법채용수궤수자표법,장80례완해기지기관효천환자수궤분위치료조화대조조,매조40례。치료조여가미삼합산,대조조여사미특라체잡송분흡입제。4주위1개료정,련복3개료정。관찰림상료효、폐공능개선정황급불량반응,검측치료전후혈기산세포계수(EOC)、혈기산성립세포양리자단백(ECP)。결과치료조총유효솔위95.00%(38/40),대조조위80.00%(32/40),치료조우우대조조(P<0.05);치료조1초용력호기용적(FEV1)점예계치백분비급FEV1/용력폐활량치균교치료전현저승고,차우우대조조(P<O.05);2조환자EOC、ECP균강저(P<0.05)。결론가미삼합산치료완해기지기관효천료효현저,가명현개선환자적폐공능,억제기산성세포취집。
Objective To observe the clinical efficacy, changes in lung function and hematological indexes of bronchial asthma in remission stage treated by Jiawei Shenge powder. Methods Eighty cases of bronchial asthma patients were randomly divided into the treatment group (40 cases) and the control group (40 cases), and were treated with Jiawei Shenge powder and Shah Mette Lo fluticasone propionate powder for inhalation therapy respectively. A course of treatment was four weeks and three courses were served. The clinical curative effect and the changes of lung function in patients, serum eosinophil count (EOC), blood eosinophil cationic protein (ECP) and adverse reaction were observed. Results The total effective rate was 95.00%(38/40) in the treatment group and that in the control group was 80.00% (32/40). There was significant difference between the two groups (P<0.05). FEV1 of expected value and FEV1/FVC value in the treatment group were significantly higher than that of before treatment, and better than those in the control group after treatment (P<0.05). EOC and ECP of the two groups decreased (P<0.05). Conclusion The treatment of Jiawei Shenge powder for bronchial asthma in remission stage is effective. It obviously improves pulmonary function in patients and inhibits the eosinophil accumulation.